|
|
|
|
| LEADER |
01590cas a2200397 4500 |
| 001 |
PPN038830345 |
| 005 |
20180607013000.0 |
| 011 |
|
|
|a 0048-5764
|
| 035 |
|
|
|a ccn0048-5764
|
| 035 |
|
|
|a issn00485764
|
| 040 |
|
|
|a PSYBB9
|
| 100 |
|
|
|a 19750921a19669999uuua1frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a US
|
| 110 |
|
|
|a aha||||0uu|
|
| 200 |
1 |
|
|a Psychopharmacology bulletin
|b Texte imprimé
|
| 210 |
|
|
|a Bethesda, Md
|c The Clearinghouse
|d 1966-
|
| 305 |
|
|
|a Publication interrompue en 1999-2000. Reprise en 2001 (volume 35, n1̊)
|
| 430 |
|
| |
|0 037445855
|t Bulletin - Psychopharmacology Service Center
|x 0376-0162
|
| 530 |
0 |
|
|a Psychopharmacology bulletin
|
| 531 |
|
|
|a Psychopharmacol. bull.
|
| 606 |
|
|
|3 PPN02728204X
|a Psychopharmacologie
|2 rameau
|
| 710 |
0 |
2 |
|3 PPN030742366
|a National clearinghouse for mental health information
|c Etats-Unis
|4 070
|
| 711 |
0 |
2 |
|3 PPN027915190
|a National institute of mental health
|c Etats-Unis
|4 070
|
| 711 |
0 |
2 |
|a International Reference Center on Psychotropic Drugs
|4 070
|
| 711 |
0 |
2 |
|3 PPN083587497
|a United States
|b Alcohol, Drug Abuse, and Mental Health Administration
|4 070
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20060619
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20060619
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b ISSN
|c 20051021
|
| 802 |
|
|
|a 01
|
| 930 |
|
|
|5 441092101:168489678
|b 441092101
|a P1607
|j f
|
| 937 |
|
|
|a BU Santé
|c : vol. 22 no. 1 (1986) - vol. 26 no. 1 (1990) ; vol. 27 no. 1 (1991) - vol. 34 no. 3 (1998)
|f Cote : P1607
|
| 955 |
4 |
1 |
|5 441092101:168489678
|a 22
|b 1
|i 1986
|a 26
|b 1
|i 1990
|
| 955 |
|
|
|5 441092101:168489678
|a 27
|b 1
|i 1991
|a 34
|b 3
|i 1998
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 370522
|
Nantilus